EUVIMEDEUVIMED entdecken
Scoping Review

Electroconvulsive Therapy in Refractory and Super-Refractory Status Epilepticus in Adults: A Scoping Review

Marjorie Jia Yi Ong iD, Vanessa Lin Lin Lee iD, Sze Lynn Teo, Hui Jan Tan iD, Eugen Trinka iD, Ching Soong Khoo iD

Neurocritical Care · 2024

DOI: 10.1007/s12028-024-02003-4 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Neurocritical Care, 2024. Verfasst von Marjorie Jia Yi Ong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Status Epilepticus, Electroconvulsive Therapy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Electroconvulsive therapy (ECT) has been suggested as a treatment option for refractory status epilepticus (RSE) and super-refractory status epilepticus (SRSE). OBJECTIVE: The objective of this scoping review was to conduct an extensive literature review on the role of ECT as a treatment option for RSE and SRSE. METHODS: We searched Ovid MEDLINE and Scopus for journal articles from database inception until February 2024. Articles were then selected based on predetermined inclusion and exclusion criteria. RESULTS: We identified five retrospective case series with 28 adult patients receiving ECT for RSE or SRSE. ECT was administered within 3-70 days (mean 20 days) after the development of SE, and the mean number of ECT courses ranged from 1 to 12 sessions for each patient. ECT was administered in fixed or titrated doses. A total of 20 out of 28 patients (71%) showed clinical improvement, with two (7%) having complete cessation of seizures. It is essential to note that given the lack of control, there could be overreporting of clinical improvement in these studies. 11 patients (39%) were reported as deceased due to causes that were not directly related to ECT treatment. Four patients (14%) reported adverse effects of ECT, including memory, concentration, and/or cognitive impairment. CONCLUSIONS: There are level-4 Oxford Centre for Evidence-Based Medicine evidence and low-level Grading of Recommendations Assessment Development and Education evidence that suggest ECT as a treatment option for RSE and SRSE. In light of the limitations of the existing evidence, clinicians should carefully consider individual patients' clinical contexts when deciding on the appropriateness of ECT as a treatment option. Further research, including prospective studies with controlled designs, is needed to elucidate the efficacy, safety, and optimal regime of ECT in the management of RSE and SRSE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Status EpilepticusElectroconvulsive TherapyHumansAdultDrug Resistant Epilepsy

Stichwörter der Autor:innen

Electroconvulsive therapyEpilepsyStatus epilepticus

Autor:innen und Institutionen

  • Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
  • Neurology Unit, Department of Medicine, Hospital Canselor Tuanku Muhriz, Kuala Lumpur, Malaysia.
  • Neuropharmacology Research Laboratory, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Subang Jaya, Selangor, Malaysia.
  • Department of Neurology, Neurocritical Care, and Neurorehabilitation, Christian-Doppler University Hospital, Paracelsus Medical University, Centre for Cognitive Neuroscience, Member of EpiCARE, Salzburg, Austria.
  • Neuroscience Institute, Christian-Doppler University Hospital, Paracelsus Medical University, Centre for Cognitive Neuroscience, Salzburg, Austria.
  • Institute of Public Health, Medical Decision-Making and HTA, UMIT - Private University for Health Sciences, Medical Informatics and Technology, Hall in Tyrol, Austria.

ORCID-Profile: Marjorie Jia Yi Ong, Vanessa Lin Lin Lee, Hui Jan Tan, Eugen Trinka, Ching Soong Khoo

Zitieren

APA

Ong, M. J. Y., Lee, V. L. L., Teo, S. L., Tan, H. J., Trinka, E., & Khoo, C. S. (2024). Electroconvulsive Therapy in Refractory and Super-Refractory Status Epilepticus in Adults: A Scoping Review. Neurocritical Care. https://doi.org/10.1007/s12028-024-02003-4

Vancouver

Ong MJY, Lee VLL, Teo SL, Tan HJ, Trinka E, Khoo CS. Electroconvulsive Therapy in Refractory and Super-Refractory Status Epilepticus in Adults: A Scoping Review. Neurocritical Care. 2024. doi:10.1007/s12028-024-02003-4

BibTeX
@article{Ong2024,
  author = {Ong, Marjorie Jia Yi and Lee, Vanessa Lin Lin and Teo, Sze Lynn and Tan, Hui Jan and Trinka, Eugen and Khoo, Ching Soong},
  title = {Electroconvulsive Therapy in Refractory and Super-Refractory Status Epilepticus in Adults: A Scoping Review},
  journal = {Neurocritical Care},
  year = {2024},
  doi = {10.1007/s12028-024-02003-4}
}
Kostenlos starten →